205 related articles for article (PubMed ID: 1824742)
21. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
22. Role of paf-acether in protamine-induced thrombocytopenia in rabbits.
Nathan N; Aissa J; Benveniste J; Arnoux B
Eur J Anaesthesiol; 1992 Jul; 9(4):347-52. PubMed ID: 1628640
[TBL] [Abstract][Full Text] [Related]
23. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
Mizutani T; Takahashi S; Kihara S; Toyooka H
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic changes after the administration of protamine.
Casthely PA; Goodman K; Fyman PN; Abrams LM; Aaron D
Anesth Analg; 1986 Jan; 65(1):78-80. PubMed ID: 3940472
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
[TBL] [Abstract][Full Text] [Related]
26. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
Vollmar B; Conzen PF; Habazettl H; Yekebas E; Peter K
J Appl Physiol (1985); 1993 May; 74(5):2412-20. PubMed ID: 8335575
[TBL] [Abstract][Full Text] [Related]
27. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
Vilahur G; Casanà L; Badimon L
Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
[TBL] [Abstract][Full Text] [Related]
28. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.
Montalescot G; Zapol WM; Carvalho A; Robinson DR; Torres A; Lowenstein E
Circulation; 1990 Nov; 82(5):1754-64. PubMed ID: 2171807
[TBL] [Abstract][Full Text] [Related]
29. Reversal of depressed oxygen consumption accompanying in vivo protamine sulphate-heparin interactions by the prostacyclin analogue, iloprost.
Wakefield TW; Wrobleski SK; Stanley JC
Eur J Vasc Surg; 1990 Feb; 4(1):25-31. PubMed ID: 1691112
[TBL] [Abstract][Full Text] [Related]
30. Reversal of low-molecular-weight heparin anticoagulation by synthetic protamine analogues.
Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Fazzalari A; Nichol BJ; Vanderkooi T; Stanley JC
J Surg Res; 1994 Jun; 56(6):586-93. PubMed ID: 8015315
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary hypertensive effect of heparin and protamine interaction: evidence for thromboxane B2 release from the lung.
Degges RD; Foster ME; Dang AQ; Read RC
Am J Surg; 1987 Dec; 154(6):696-9. PubMed ID: 3425821
[TBL] [Abstract][Full Text] [Related]
32. [Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin].
Montalescot G
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):555-60. PubMed ID: 2111678
[TBL] [Abstract][Full Text] [Related]
33. Imaging the ovine heparin-protamine interaction with 111In-protamine.
Montalescot G; Fischman AJ; Strauss HW; Wilkinson RA; Ahmad M; Fitzgibbon C; Robinson DW; Zapol WM
J Appl Physiol (1985); 1993 Aug; 75(2):963-71. PubMed ID: 8226502
[TBL] [Abstract][Full Text] [Related]
34. Role of platelet-activating factor in the ovine heparin-protamine reaction.
Montalescot G; Huerta JM; Braquet P; Zapol WM
J Appl Physiol (1985); 1992 Dec; 73(6):2604-7. PubMed ID: 1490976
[TBL] [Abstract][Full Text] [Related]
35. Effects of BM-573, a thromboxane A2 modulator on systemic hemodynamics perturbations induced by U-46619 in the pig.
Tchana-Sato V; Dogné JM; Lambermont B; Ghuysen A; Magis D; Morimont P; Hanson J; D'Orio V; Limet R; Kolh P
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):82-95. PubMed ID: 16303607
[TBL] [Abstract][Full Text] [Related]
36. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
De Clerck F; Beetens J; Van de Water A; Vercammen E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):43-9. PubMed ID: 2526385
[TBL] [Abstract][Full Text] [Related]
37. Protamine-induced pulmonary venoconstriction in heparinized pigs.
Hakim TS; Picone A; Oleary CE; Camporesi EM
Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
[TBL] [Abstract][Full Text] [Related]
38. [The effects of thromboxane receptor antagonist on hemodynamic responses after neutralization of heparin by protamine].
Yoshioka M; Wakamatsu M; Kuro M; Okumura F
Masui; 1991 Jun; 40(6):918-22. PubMed ID: 1875538
[TBL] [Abstract][Full Text] [Related]
39. Effect of a thromboxane synthetase inhibitor on protamine-induced circulatory changes in sheep.
Sugi K; Esato K
Surgery; 1993 Sep; 114(3):586-90. PubMed ID: 8367815
[TBL] [Abstract][Full Text] [Related]
40. Heparin-mediated reductions of the toxic effects of protamine sulfate on rabbit myocardium.
Wakefield TW; Wrobleski SK; Nichol BJ; Kadell AM; Stanley JC
J Vasc Surg; 1992 Jul; 16(1):47-53. PubMed ID: 1619724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
